Mechanisms of Inhibition of Intestinal SERT by EPEC Infection.
Mechanisms of Inhibition of Intestinal SERT by EPEC Infection.
批准号:
8356809
负责人:
Ravinder K Gill
金额:
$6.3万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2014-07-31
关键词:
5 year oldAcuteApplications GrantsBacteriaCause of DeathCell CountCell modelCessation of lifeChildChildhoodComplexDiarrheaDiseaseDrug Delivery SystemsEnteralEnterochromaffin CellsEnterotoxinsEpithelialEpithelial CellsEscherichia coli InfectionsEventFunctional disorderGoalsHealthHomeostasisIn VitroInfantInfantile DiarrheaInfectionInfectious AgentInflammatoryInflammatory Bowel DiseasesInflammatory disease of the intestineIntestinesIonsIrritable Bowel SyndromeLiquid substanceMicrobeModalityModelingMolecularMorbidity - disease rateMusOral Rehydration TherapyOutcome StudyPathogenesisPharmaceutical PreparationsPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhysiologicalProcessProtein DephosphorylationProtein Tyrosine PhosphataseProteinsRegulationResearchRoleSerineSerotoninSignal TransductionTherapeuticThreonineToxinType III Secretion System Pathwayabsorptionbasecell motilityenteropathogenic Escherichia colifoodbornefoodborne pathogengastrointestinalileumin vivoin vivo Modelinsightkillingsmicrobial hostmortalitymouse modelmutantnovelnovel strategiespathogenpreventresponseserotonin transporteruptake
中文摘要
描述(由申请人提供):由传染性病原体引起的腹泻病继续构成严重的健康问题,特别是对婴儿。因此,有必要开发新的有效药物来治疗腹泻。肠道5-羟色胺转运蛋白(SERT)参与调节肠道5-羟色胺的可用性,是一个重要的候选靶点,因为
英文摘要
DESCRIPTION (provided by applicant): Diarrheal diseases caused by infectious agents continue to pose a serious health problem, especially in infants. It is, therefore, necessary to develop novel efficacious drugs to treat diarrhea. Intestinal serotonin transporter (SERT), involved in regulation of luminal 5-HT availability, is an important candidate to target because of
its implications in several diarrheal disorders. The proposed studies are focused at examining the role of serotonin transporter (SERT) in the pathophysiology of diarrhea associated with infection by an important food-borne pathogen, Enteropathogenic E. coli (EPEC). Because of the lack of a known toxin, pathophysiology of EPEC-induced early diarrhea remained elusive for many years. Emerging studies have revealed that mechanism(s) underlying EPEC associated diarrhea are multi-factorial. Our recent studies showed that EPEC inhibits SERT in the intestinal epithelial cells via activation of protein tyrosine phosphatases. However, the detailed mechanisms underlying EPEC induced inhibition of SERT are not known. We hypothesize that EPEC induced signaling events alter SERT phosphorylation levels to cause its inhibition that may contribute to associated diarrhea. The present studies will systematically examine the effects of EPEC infection on SERT utilizing both in vitro and in vivo models. Studies proposed in Specific Aim 1 will identify the specific serine/threonine/tyrosine phosphatases involved in SERT modulation post-infection and will identify the structural domains that harbor SERT phosphorylation site(s). Specific Aim 2 will critically elucidate the mechanisms of acute inhibitio of SERT in response to EPEC infection by assessing the role of cellular phosphatases in the native mouse ileum. In addition, the effect of phosphatases on serotonergic machinery (5-HT synthesis and release) will be examined to model the net impact of EPEC infection in complex native intestine. Overall, the proposed studies will help provide valuable insights into the host-microbial epithelial interaction underlying pathophysiology of EPEC- associated diarrhea as well as will increase our understanding of phosphorylation/dephosphorylation mechanisms governing SERT activity under physiological and pathophysiological conditions.
PUBLIC HEALTH RELEVANCE: Diarrheal disease is the second leading cause of death in children under five years old, and is responsible for killing 1.5 million children every year. Therefore, it is important to discover new drugs that can effectively treat diarrhea. Our studies are aiming to investigate how a food-borne bacterium, EPEC modulates intestinal serotonin transporter (SERT) to cause diarrhea. Because of implication of SERT in diarrheal disorders, the outcome of these studies may provide new insights into therapeutic modalities for intestinal infectious or diarrheal disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of intestinal serotonin transporter in post traumatic stress disorder
-
批准号:10590033
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2024
-
负责人:Ravinder K Gill
-
依托单位:
Intestinal 5-HT Transporter: A novel therapeutic target for GI disorders
-
批准号:8629924
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2014
-
负责人:Ravinder K Gill
-
依托单位:
Intestinal 5-HT Transporter: A novel therapeutic target for GI disorders
-
批准号:10316170
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2014
-
负责人:Ravinder K Gill
-
依托单位:
Intestinal 5-HT Transporter: A novel therapeutic target for GI disorder
-
批准号:10361310
-
项目类别:
-
资助金额:$3.26万
-
财政年份:2014
-
负责人:Ravinder K Gill
-
依托单位:
Mechanisms of Inhibition of Intestinal SERT by EPEC Infection.
-
批准号:8487402
-
项目类别:
-
资助金额:$6.08万
-
财政年份:2012
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7078067
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7671351
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7921606
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7805000
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:7483111
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
Anion Transport in EPEC Induced Diarrhea
-
批准号:8128440
-
项目类别:
-
资助金额:$13.58万
-
财政年份:2007
-
负责人:Ravinder K Gill
-
依托单位:
海外基金